GSK grabs more diagnostics; FDA warns J&J's Bengay can cause burns; China studies psychotropics;

 @FiercePharma: Sanofi eyes emerging market buyouts beyond the BRICs. Article | Follow @FiercePharma

> GlaxoSmithKline ($GSK) has upped its position in companion diagnostics firm Response Genetics to 15.2%. Story 

> China has established China Academic Research Organization of Psychotropic (China AROP), to research psychotropic drugs as part of its development plan for the 2011-2015 period. Story 

> Australia-based Sirtex Medical reported a 27% increase in its U.S. sales of its radioembolization treatment for inoperable liver cancer in fiscal 2012 to $59 million. Release 

> In the report "Healthcare, Regulatory and Reimbursement Landscape - Mexico" analysts estimate that the pharmaceuticals market in Mexico will reach approximately $22.5 billion by 2020 at a projected CAGR of 7%. Release 

> Indian drugmaker Lupin has received FDA approval to make a generic version of Forest Laboratories' Lexapro. Story

Biotech News

 @FierceBiotech: Sanofi inks $163M tech pact to speed cancer drugs to clinic. News | Follow @FierceBiotech

 @JohnCFierce: 4SC spotlights partnership talks after liver cancer combo (with Nexavar) extends survival. More | Follow @JohnCFierce

 @RyanMFierce: Viehbacher reminded folks in China that Sanofi sees good emerging market opportunities beyond BRIC countries. More | Follow @RyanMFierce

> GW Pharma IDs promising epilepsy drug in cannabis. Report

> General Dynamics lands a $42M DoD drug development contract. News

> Sanofi snags FDA OK for oral MS drug Aubagio, prices at $45K. News

Medical Device News

 @FierceMedDev: Asia isn't the only growth market: KCI is expanding in Brazil. Release | Follow @FierceMedDev

 @MarkHFierce: Covidien is closing a SC plant and slashing nearly 600 full time and contract jobs. Story | Follow @MarkHFierce

 @DamianFierce: A St. Jude exec says the device tax wasn't the sole cause of the company's job cuts and restructuring. Item | Follow @DamianFierce

> J&J/Ethicon invests $185M in surgical suture plant expansion. Article

> iWalk pulls in $17M for bionic limbs. News

> Study: Dune's MarginProbe cuts down on repeat cancer surgery. More

Pharma Manufacturing News

> Endo recalls potentially 'super potent' painkillers. News

> Sartorius opens $23M bioreactor plant. More

> Canada issues new ranking system for plant violators. Story

> Pfizer injects cloud computing into complex supply chain. Article

Vaccines News

> Potential allergy cure is just under the skin. Article

> HHS awards flu antigen contract to CSL. News

> WHO injects Prevnar 13 with adult prequalification status. More

> Sanofi's dengue vaccine falters in clinical trial. Story

And Finally... Bengay from Johnson & Johnson ($JNJ) and Icy Hot from Sanofi ($SNY) have been tied to 43 reports of burns, mostly second and third degree, the FDA reports today. Story

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.